AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2021
Feb 4, 2021
29745_dirs_2021-02-03_9553f4ce-9823-4e15-8103-3da9795f6f2a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-02-01
Reporting Person: Ricks David A (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | M | 75387 | — | Acquired | 343639 | Direct |
| 2021-02-01 | Common Stock | F | 33738 | $207.97 | Disposed | 309901 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-01 | Restricted Stock Unit | $ | M | 75387 | Disposed | 2021-02-01 | Common Stock (75387.0) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6931 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 11
Prospectus
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Prospectus
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 20